Pelvic organ mobility after treatment for uterine descent
Recruiting
- Conditions
- prolapseuterine descent1004682810029903
- Registration Number
- NL-OMON41071
- Lead Sponsor
- Isala Klinieken
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 15
Inclusion Criteria
Patients who recently underwent a vaginal hysterectomy, vaginal sacrospinous hysteropexy and laparoscopic sacrohysteropexy as a primary treatment for uterine descent (without surgery for prolapse or hysterectomy in the past)
Exclusion Criteria
Factors that will preclude MRI interpretation (e.g. prosthetic hip)
Contra-indications for MRI (e.g. claustrophobia, metal clips)
Not physically able to maintain Valsalva maneuvre for at least 10 seconds (e.g. pulmonary problems)
Neurological disease affecting the pelvic floor
Previous pelvic floor surgery
Study & Design
- Study Type
- Observational invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Primary outcome is the mobility of the pelvic organs (displacement of the<br /><br>bladder, vagina, cervix or apex and rectum) between three commonly performed<br /><br>treatment options for uterine descent. </p><br>
- Secondary Outcome Measures
Name Time Method <p>Secondary outcome is the correlation between the clinical results (MRI<br /><br>findings, POP-Q assessment) and symptoms of POP. </p><br>